M Pharmaceutical Inc. has named highly-touted University of Calgary gastrointestinal surgeon and diabetes researcher Dr. Oliver Frank Bathe, MD, MSc, FRCS(C), FACS, to its Advisory Board, effective immediately. Dr. Bathe currently serves at the Division of Surgical Oncology at the Tom Baker Cancer Centre and is a member of the Julia McFarlane Diabetes Center at the University of Calgary, brings to M Pharmaceutical Inc. an impressive background in a number of specializations, including metabolomics, cancer surgery, epidemiology, and critical care.